Retail · Deep dive
Petco Health and Wellness
The 1965 San Diego mail-order vet-supply house that became a ~1,400-store pet retailer, went through five ownership flips including a $4.6B CVC/CPP Investments LBO, re-IPO'd at $18 in January 2021, collapsed to ~$2.60, and is now running a three-phase turnaround under ex-Five Below CEO Joel Anderson — ~$6.0B of sales, ~$408M EBITDA, ~$1.5B of debt, and roughly 300 in-store vet hospitals as the differentiator Chewy and Amazon can't ship.
at risk
Anderson's turnaround is real — EBITDA up 21% and comps positive again by mid-2026 — but a shrinking ~$6B top line, ~$1.5B of LBO-era debt against ~$410M EBITDA, sponsor control at 65.85%, and structural share loss to Chewy, Amazon and mass retail mean Petco is repairing itself faster than it is defending itself.
My take
- HQ
- San Diego, CA
- Founded
- 1965 (as UPCO, a mail-order veterinary supply company)
- Ownership
- Public (Nasdaq: WOOF) but sponsor-controlled: CVC Capital Partners and CPP Investments held 65.85% through Scooby Aggregator LP as of the May 2025 proxy — a 'controlled company' under Nasdaq rules since the 2016 LBO
- Funding
- Serial buyout target: 1994 Nasdaq IPO (PETC); 2000 take-private by Leonard Green & TPG; 2002 re-IPO; 2006 Leonard Green/TPG take-private at ~$1.7B; January 2016 close of the ~$4.6B CVC Capital Partners / CPP Investments LBO; January 2021 re-IPO at $18/share raising ~$939M net (used for debt paydown); January-February 2026 refinancing of the term loan into ~$900M of new facilities plus $600M senior secured notes
- Valuation
- Market capitalization roughly $745-770M at ~$2.60/share (July 24, 2026), down from an ~$4B IPO valuation in January 2021, ~$3B as recently as February 2023 and ~$784M at the March 2024 CEO exit; enterprise value roughly $2B adding ~$1.48B total debt (Q1 FY2026) less ~$257M cash (Jan 2026), before ~$2B+ of operating leases
- Revenue
- Net sales of $6.0B in fiscal 2025 (year ended Jan 31, 2026), down 2.5%, vs $6.1B in FY2024, $6.3B in FY2023, $6.04B in FY2022, $5.8B in FY2021 and ~$4.9B in FY2020; FY2025 net income $9.1M (first full-year profit since FY2022) on adjusted EBITDA of $408.2M, up 21.3%; Q1 FY2026 (reported June 3, 2026) net sales $1.5B, comps +0.7%, adjusted EBITDA $97.3M (company releases)
- Headcount
- On the order of 26,000-29,000 'partners' per company disclosures in 2023-2025, the large majority hourly store, grooming and Vetco staff; headcount has drifted down with ~25 net store closures in fiscal 2024 and a planned 20-30 more in 2025
- Screen
- PE-owned incumbent — majority-controlled by CVC Capital Partners and CPP Investments since the ~$4.6B 2016 buyout; ~$6.0B FY2025 revenue across ~1,400 U.S. pet care centers plus vet services
- Published
- 2026-07-25
- Web
- www.petco.com
- Elsewhere
- LinkedIn · Crunchbase
Founders and leadership
-
Joel Anderson Chief Executive Officer (since July 2024)
The turnaround hire, and the closest thing Petco has to a refounder. Anderson spent nearly a decade as CEO of Five Below (2015-2024), scaling the discount chain from 361 stores to more than 1,600 and revenue from ~$500M to over $3.5B; before that he ran Walmart.com as president and CEO. His playbook at Petco is deliberately unglamorous: Phase 1 restored profitability and cash discipline, Phase 2 rebuilt retail fundamentals (assortment, inventory, expense control), and Phase 3 — 'Reach for the Sky,' unveiled with fiscal 2025 results in March 2026 — chases top-line growth through product newness and 'drops,' 1,000+ fresh-food freezers in 2026, owned-brand expansion and a loyalty relaunch. He left the high-growth Five Below job abruptly for a broken, sponsor-controlled retailer — a bet that the equity, at a sub-$1B market cap, is a cheap option on execution.
-
Walter Evans Founder (1965, as UPCO)
Evans founded United Pharmacal Company (UPCO) in San Diego in 1965 as a mail-order veterinary supply business with five associates — animal health first, retail later. The first retail store opened in La Mesa, California in 1976, the company took the Petco name in 1979, and a 1988 acquisition of two chains tripled the store base from 40 to 130. The irony of the current strategy is that Petco is reaching back to its origin: it began as a pet-health company that added stores, and is now a store chain trying to become a pet-health company again.
-
CVC Capital Partners & CPP Investments (sponsors) Controlling owners since January 2016
CVC's Fund VI and Canada Pension Plan Investment Board bought Petco from Leonard Green & Partners and TPG for approximately $4.6B in a deal announced November 2015 and closed early 2016 — the fourth private-equity flip of the company. They took it public again in January 2021 at $18/share, near the top of the pandemic pet boom, but sold little: through Scooby Aggregator LP they still held 65.85% at the May 2025 proxy, making Petco a controlled company whose board answers to sponsors sitting on a large unrealized loss, roughly a decade into the hold.
Snapshot
Petco is a ~1,400-store U.S. pet retailer (plus Mexico and Puerto Rico) that has spent a decade trying to become a healthcare company — roughly 300 full-service vet hospitals inside its stores, ~1,600 weekly low-cost Vetco vaccination clinics, 1,410+ grooming salons, and a $24.99/month Vital Care membership stapling it together (company disclosures, March 2026). It did $6.0B of net sales in fiscal 2025 (ended January 31, 2026), down 2.5%, and its equity tells the harsher story: re-IPO’d at $18 in January 2021 near the top of the pandemic pet boom, the stock traded around $2.60 in late July 2026 — a ~$745M market cap under ~$1.48B of debt, with LBO sponsors CVC Capital Partners and CPP Investments still holding 65.85%. It matters now because the turnaround has a pulse — EBITDA up 21.3% in FY2025, the first annual profit since FY2022, positive comps in Q1 FY2026 — while the structural question, whether a leveraged big-box chain can defend against Chewy, Amazon and mass retail, stays open.
Founding story
Petco began in 1965 as UPCO — United Pharmacal Company — a San Diego mail-order veterinary supply business founded by Walter Evans with five associates. Retail came second: the first store opened in La Mesa, California in 1976, the Petco name arrived in 1979, and a 1988 acquisition of two chains tripled the footprint from 40 to 130 stores.
The more consequential story is the ownership carousel. Petco IPO’d on Nasdaq in 1994, was taken private by Leonard Green & Partners and TPG in 2000 for $600M, relisted in 2002, and was taken private again by the same pair in 2006 for roughly $1.7B — the same asset flipped twice by the same sponsors. In November 2015, after a dual-track auction, CVC Capital Partners (Fund VI) and CPP Investments agreed to buy Petco for approximately $4.6B, closing in early 2016 — a heavily levered secondary buyout at peak pet-retail confidence, months before Chewy made the danger obvious. The January 2021 re-IPO at $18 ($939M net proceeds, used to pay down debt) valued the company near $4B and let the sponsors mark, but not exit: they still controlled 65.85% at the May 2025 proxy, with the equity down ~86% from the offer price (July 24, 2026). Every strategic decision since reads partly as an attempt to manufacture an exit story for owners who missed their window.
How it works
A Petco “pet care center” is a box engineered to generate trips ecommerce cannot serve. The front is merchandise — food, treats, litter, supplies, live animals and aquatics — with consumables about half of sales (Q4 FY2025: $759M consumables, $500M supplies and companion animals, $256M services and other). The back is the wellness flywheel: a grooming salon (1,410+ locations), dog training, and in ~300 stores a full-service Vetco Total Care veterinary hospital doing exams, diagnostics and dentistry; another ~1,600 Vetco vaccination clinics a week run as pop-ups offering low-cost shots and microchipping without an exam fee. Services exist to create appointments — a groom every six weeks, an annual exam — and each appointment walks a customer past the kibble aisle.
Vital Care is the monetization layer on top. The paid tier (Vital Care Premier, being folded into a “Petco Perks Premier” relaunch in 2026) costs $24.99/month for a dog or cat — raised from $19.99 — or $239.99/year, with a 12-month commitment; small-animal plans run $9.99/month. Members get $15/month in rewards, routine-exam benefits at Vetco, and discounts on nutrition and grooming (petco.com, 2026). It is a Costco-style membership grafted onto vet care — an annuity plus share-of-wallet — and store staff carry explicit Premier sign-up quotas, a recurring theme in employee reviews. Owned brands (WholeHearted, Reddy and five other priority labels, ~20% of sales; WholeHearted past $1B cumulative) carry margins management calls significantly above national brands and cannot be price-compared line-for-line on Amazon.
Product and business overview
Three named components. Merchandise — consumables (~half of revenue) plus supplies and companion animals — is the volume engine and the most contested ground, sold in-store and through a site/app with same-day fulfillment from stores. Services — grooming, training, insurance referrals and the vet stack (hospitals, Vetco clinics, online pharmacy) — is the strategic bet, growing toward a mid-teens share of sales even as merchandise shrank (management commentary, 2025-2026). Membership and owned brands — Vital Care/Petco Perks and the private-label portfolio — is the margin repair kit. Under Anderson the logic inverted: services anchor traffic while merchandising discipline (newness, drops, fresh-frozen food via 1,000+ new freezers in 2026) tries to win back the routine basket lost to cheaper channels.
Business model and pricing
Revenue is booked overwhelmingly as product sales at retail margin, plus service fees (a full-service dog groom typically runs ~$45-90 depending on size and market, per published guides, 2025) and Vital Care subscriptions. Gross margin was 38.7% in FY2025, up 66bps — far above Chewy’s ~29.8% because services and private label are richer than shipped kibble — but ~1,400 leases and hospital staffing consume most of it: operating margin was just 2.0% (up 190bps). Vet economics are loss-leader-ish at entry — Vetco clinics undercut independent vets on vaccines — with the payoff meant to come from exam-driven product attach and Premier conversion. The capital structure taxes everything: ~$1.48B of debt (Q1 FY2026) against $408M of adjusted EBITDA is ~3.6x gross leverage before $2B+ of leases, and the January-February 2026 refinancing ($900M new term facilities plus $600M senior secured notes, replacing a term loan due 2028) bought time at the cost of tighter covenants and higher coupons. Interest is why a $408M-EBITDA company earned just $9.1M of net income in FY2025.
Traction over time
| Fiscal year (ends ~late Jan) | Net sales | Comps | Net income / (loss) | Adjusted EBITDA | Notes |
|---|---|---|---|---|---|
| FY2020 | ~$4.9B | +~17% | ~breakeven | — | Pandemic adoption boom |
| FY2021 | $5.8B | +18% rev. growth | $164.4M | ~$591M | Peak year; record everything |
| FY2022 | $6.04B | +4.5% | $90.8M | ~$570M | Growth stalls as boom fades |
| FY2023 | $6.3B | +~0.3% | ($1.3B) | ~$434M (guided $520-540M in early 2023, cut to ~$400M by Nov) | $1.2B goodwill impairment; guidance credibility breaks |
| FY2024 | $6.1B | negative | ($101.8M) | ~$336M | Coughlin out (Mar 2024); Anderson in (Jul 2024); 25 net closures to 1,398 U.S. stores |
| FY2025 | $6.0B | -1.6% | $9.1M | $408.2M (+21.3%) | First profit in three years; $95M voluntary debt paydown; cash $256.7M |
| Q1 FY2026 | $1.5B | +0.7% | — | $97.3M | First positive comp of the Anderson era; FY26 guide: sales flat to +1.5%, EBITDA $415-430M |
(Company releases, March 2022-June 2026.) The shape: a pandemic sugar-high, three years of decline and losses, then a profitability-first repair that stabilized earnings while revenue still shrinks. The FY2026 guide concedes the point — even the bull case is roughly flat sales.
Market analysis
The market is genuinely good; Petco’s position in it is not. U.S. pet spending reached $158B in 2025, up 3.7%, with APPA projecting 4.4% growth to ~$165B in 2026 — food and treats at $68.3B, veterinary care at ~$41B (APPA State of the Industry, 2026). The structural forces are pet humanization (premium diets, diagnostics, insurance), millennial/Gen-Z ownership, and an undersupplied vet system that keeps service prices inflating. But the goods side — most of Petco’s revenue — is deflationary and channel-shifting: consumables migrate to Chewy Autoship and Amazon, value shoppers trade down to Walmart, Costco and private label, and APPA found 22% of owners cut pet spending in 2025. Petco is over-indexed to the slow, contested half of a growing market and under-scaled in the fast half, where Mars and PE roll-ups own the supply of veterinarians.
Competitive intel
Chewy ($12.60B FY2025 net sales, $8.5B market cap in July 2026) is the primary predator: 84% Autoship penetration turns Petco’s highest-frequency category into someone else’s subscription, and Chewy is now opening its own vet clinics — attacking the moat, not just the aisle. PetSmart ($9-10B estimated 2024 revenue, ~1,660 stores, BC Partners-owned) is the bigger box fighting the same war with Banfield clinics inside; the two split a shrinking store-based market. Amazon, Walmart, Target and Costco win the pantry-reload trip on price; Walmart’s pet pharmacy and clinic experiments push directly into services. Tractor Supply ($15.52B FY2025 sales) owns the rural/value pet customer and bought online pharmacy Allivet (closed December 2024). Mars Petcare (VCA, Banfield, ~2,000+ clinics) plus roll-ups like Thrive Pet Healthcare dominate vet capacity and bid up the veterinarians Petco’s hospitals must recruit. Petco’s remaining edge: it is the only national player combining products, grooming and affordable walk-in vet access under one roof and one membership — an integration none of the specialists can copy cheaply, and one that only pays if Vital Care converts traffic into loyalty faster than the aisles empty.
History and evolution
- 1965 — Walter Evans founds UPCO, mail-order vet supplies, San Diego.
- 1976-1979 — First retail store (La Mesa, CA); renamed Petco.
- 1988 — Acquires two chains; 40 → 130 stores.
- 1994 — IPO #1 on Nasdaq (PETC).
- 2000 / 2002 / 2006 — Leonard Green & TPG take it private (
$600M), relist it, then take it private again ($1.7B). - January 2016 — CVC Capital Partners and CPP Investments close the ~$4.6B LBO (announced November 23, 2015).
- June 2018 — Ron Coughlin (ex-HP, PepsiCo) becomes CEO; rebrands to “Petco, The Health + Wellness Co.”, pulls artificial ingredients and shock collars, accelerates vet-hospital builds.
- January 2021 — IPO #3 at $18/share (~$939M net, used for debt paydown); ~$4B valuation; ticker WOOF.
- 2023 — Boom unwinds: early-2023 adjusted-EBITDA guidance of $520-540M is slashed to ~$400M by November; FY2023 ends with a $1.3B net loss including a $1.2B goodwill impairment.
- March 13, 2024 — Coughlin steps down; shares had fallen from a ~$3B market cap in February 2023 to ~$784M; board director and ex-Best Buy COO Mike Mohan becomes interim CEO.
- July 2024 — Joel Anderson (Five Below) named CEO; pauses new vet-hospital construction until at least 2027; profitability-first Phase 1/2 begins; 25 net store closures in fiscal 2024, 20-30 more planned for 2025.
- January-February 2026 — Refinances the ~$1.5B term loan due 2028 into ~$900M of new facilities plus $600M senior secured notes.
- March 11, 2026 — FY2025 results: $6.0B sales (-2.5%), $408.2M adjusted EBITDA (+21.3%), $9.1M net income; unveils Phase 3 “Reach for the Sky” (freezers, drops, owned brands, 2026 loyalty relaunch).
- June 3, 2026 — Q1 FY2026: comps +0.7%, adjusted EBITDA $97.3M, debt down to $1.482B; guidance reaffirmed.
What people say
The case for. Sell-side sentiment turned from despair to grudging respect through 2026: Goldman Sachs called Q1 FY2026 “an inflection point” and lifted its target to $4.14 (June 5, 2026); Morgan Stanley tripled its target to $6, framing ~75% upside to a $9 bull case; Evercore ISI nudged up to $3.50. The bull argument is operational: EBITDA up 21.3% in a down-revenue year, a first positive comp, voluntary debt paydown, and a CEO with a documented scaling record. Customers praise the parts Chewy can’t replicate — cheap Vetco vaccine clinics, in-person grooming, adoption events — and trade press (dvm360) credits Vital Care as a genuine wellness membership, now covering routine exams and a dedicated cat plan. Indeed reviews call grooming pay and training decent for the sector.
The complaints. The loudest customer theme is Vital Care billing: PissedConsumer’s ~1,500 Petco reviews and ComplaintsBoard threads are dense with memberships that auto-renew into 12-month obligations, cancellations that fail, and refunds that never arrive — banks’ fraud departments reportedly field routine Petco billing disputes (2024-2026). Grooming complaints cluster on price discrepancies between stores, long waits despite appointments, and ignored instructions for anxious pets. Store staff describe relentless Premier sales quotas (“management cares about sign-ups, not pets”), thin floor coverage and low hourly pay — the labor cost of a membership-led strategy. The bear case on the equity is blunter: three straight years of revenue decline; ~$1.48B of debt against ~$410M of EBITDA; a February 2026 refinancing that came with tighter covenants and refinancing risk stacking again if the ABL isn’t extended ahead of the new maturities (TipRanks/Globe and Mail, 2026); and a 65.85% sponsor position that overhangs any recovery with a secondary flood. Citi cut to $3.25 in June 2026 on a weaker consumer. Consensus: Hold, targets in the $3s — pricing a rescue in progress, not a franchise.
Outlook: well positioned or at risk?
At-risk. The honest version of the bull case is that Petco was so badly run in 2021-2023 that competent retailing alone — Anderson’s Phases 1 and 2 — could add $70M+ of EBITDA in a year, and it did (FY2025: $408.2M, +21.3%). Comps went positive in Q1 FY2026, gross margin is rebuilding, debt is down $111M year-over-year, and guidance is credible again after the 2023 debacle. If Anderson repeats even a fraction of his Five Below execution, the sub-$1B equity on a ~$2B enterprise value is a leveraged call option with real convexity — which is why Morgan Stanley’s bull case is $9.
But an incumbent verdict is about the defensibility of the position, and Petco’s is eroding on every front that matters. The half of revenue that drives trips — consumables — is structurally migrating to Chewy’s 84%-Autoship machine, Amazon and mass-retail price leaders; freezers, drops and own brands improve the store but do not reverse the channel. The differentiated half — vet care — is the right idea executed under-capitalized: new hospital builds are paused until 2027 while Mars, Thrive and now Chewy add capacity, and the membership monetizing it generates as many billing complaints as loyalty. The balance sheet forecloses real offense: at ~3.6x gross leverage on covenant-tightened 2026 paper, cash goes to interest and paydown. And the 65.85% sponsor stake means the company is managed toward an exit for owners underwater since 2016, not a decade-long rebuild. The equity may well work from $2.60 — turnarounds this operationally credible often do — but the business is fighting for stabilized, low-single-digit-margin survival in a market whose growth accrues to its competitors. That is the definition of at-risk.
How a challenger would attack it
Attack the membership where it bleeds. Petco’s monetization layer is its most vulnerable surface: Vital Care Premier generates ~1,500 PissedConsumer reviews dense with auto-renew traps, failed cancellations and bank-disputed charges, sold by store staff working under sign-up quotas they resent. A challenger builds the anti-Vital-Care — a transparent, cancel-anytime pet wellness membership bundling telehealth triage, pharmacy and mobile-vet visits — and markets it directly against the billing horror stories. The economics work because Petco’s paused hospital build-out (frozen until 2027 by the balance sheet) leaves affordable vet access undersupplied exactly as Chewy proves clinic economics; an asset-light challenger partnering with independent vets rather than employing them sidesteps the Mars-inflated veterinarian labor market Petco must bid into. Second vector: the services-without-the-box play. Grooming complaints cluster on inter-store price discrepancies, long waits and ignored instructions — a mobile-grooming or appointment-first operator with consistent pricing takes the six-week recurring visit that is Petco’s whole traffic thesis. Third: Petco cannot counterattack. At ~3.6x gross leverage under covenant-tightened 2026 paper, with sponsors 86% underwater managing toward exit, every defensive investment competes with interest payments. The challenger’s real advantage is that Petco’s owners need EBITDA now and cannot afford a price war or a rebuild.
Same playbook, new buyer
Run the services-anchored-retail flywheel where the boxes don’t exist. Petco’s actual insight — recurring services (grooming, vaccines, exams) generate trips that ecommerce can’t serve, and a membership staples the wallet — is sound; its execution is trapped in 1,400 legacy leases and LBO debt. The playbook transfers three ways. First, small-format vet-and-grooming-led stores in the suburban and rural markets Tractor Supply owns on feed but underserves on care — a 3,000-square-foot clinic-plus-salon with a curated consumables wall is the Petco thesis without the Petco box, and Vetco’s own low-cost pop-up clinic model proves demand at ~1,600 events a week. Second, the Mexico expansion Petco already half-owns but starves: Latin American pet humanization is a decade behind the US curve with no entrenched big-box rival. Third, invert the mix — a care-first company (membership, hospitals, pharmacy) that treats retail as attach rather than anchor, which is what Chewy is building and what Petco’s 1965 UPCO origin actually was. Petco cannot follow any of these: new-format capex is foreclosed by the covenant stack, hospital builds are paused until 2027, and a sponsor-controlled board a decade into an underwater hold will not fund a five-year format experiment over near-term EBITDA.
Sources and further reading
- Petco Reports Fourth Quarter and Full Year 2025 Results — Petco IR, March 11, 2026. FY2025: $6.0B sales (-2.5%), $408.2M adjusted EBITDA, $9.1M net income, $95M debt paydown.
- Petco Reports First Quarter 2026 Results — Petco IR, June 3, 2026. Comps +0.7%, adjusted EBITDA $97.3M, total debt $1.482B, guidance reaffirmed.
- Petco outlines ‘Reach for the Sky’ strategy — Seeking Alpha, March 2026. Phase 3 plan: freezers, drops, ~20% owned-brand mix, loyalty relaunch.
- Petco announces $4.6B sale to CVC, Canadian Pension — Retail Dive, November 2015. The LBO, plus the Leonard Green/TPG 2000-2006 history.
- Petco collects $939 million from IPO — Pet Food Processing, January 2021. $18/share pricing, ~$4B valuation, proceeds to debt paydown.
- Petco CEO Ron Coughlin is out, former Best Buy exec to step in — CNBC, March 13, 2024. The exit, the ~$784M market cap, Mike Mohan interim.
- Petco Announces Launch of Debt Refinancing Transaction — Petco IR, January 12, 2026. Refinancing ~$1.5B term loan; completed February 2026 with new facilities and $600M secured notes.
- Petco (WOOF) 2026 proxy — controlled board structure — StockTitan/SEC, 2026. Scooby Aggregator LP (CVC/CPP Investments) at 65.85%.
- U.S. Pet Industry Reaches $158 Billion in 2025 — APPA, 2026. Market size, category splits, 2026 growth forecast.
- Petco is closing dozens of stores in 2025 — Fast Company, 2025. 25 net closures in 2024 to 1,398 U.S. stores; 20-30 planned for 2025.
- Petco Vital Care membership — Petco.com, 2026. Premier pricing: $24.99/month or $239.99/year dogs and cats; $9.99/month small pets.
- 1.5K Petco Reviews — PissedConsumer, 2024-2026. Recurring Vital Care billing/cancellation and grooming complaints.
- Petco Health and Wellness Company (WOOF) Statistics & Valuation — StockAnalysis, July 2026. ~$2.60 share price, ~$745M market cap.
Capital history
| Date | Round | Amount | Valuation | Lead(s) |
|---|---|---|---|---|
| 1965 | Founding (UPCO) | Bootstrapped | Mail-order veterinary supplies, San Diego; renamed Petco in 1979 | Walter Evans |
| 1994 | IPO #1 (Nasdaq: PETC) | — | Public debut of the superstore chain | — |
| 2000 | Take-private #1 | ~$600M | Leonard Green & Partners and TPG take Petco private | Leonard Green & Partners, TPG |
| 2002 | IPO #2 | — | Sponsors relist the company within two years | Leonard Green & Partners, TPG |
| 2006 | Take-private #2 (LBO) | ~$1.7B | Leonard Green and TPG re-acquire the company they had just exited | Leonard Green & Partners, TPG |
| 2016-01 | LBO #3 — CVC / CPP Investments | ~$4.6B enterprise value | Announced November 23, 2015; closed early 2016 after a dual-track auction/IPO process; heavily debt-funded | CVC Capital Partners (Fund VI), CPP Investments |
| 2021-01 | IPO #3 (Nasdaq: WOOF) | ~$939M net proceeds (55.2M shares incl. greenshoe at $18, above range) | ~$4B; proceeds used to pay down LBO debt; sponsors retained control | Goldman Sachs, BofA (underwriters) |
| 2026-02 | Debt refinancing | ~$900M new term facilities + $600M senior secured notes | Launched January 12, 2026 to refinance the ~$1.5B term loan due 2028; extends maturities under tighter covenants; total debt $1.482B at Q1 FY2026 vs $1.593B a year earlier | Lender group |
Investors / owners: CVC Capital Partners and CPP Investments — 65.85% combined via Scooby Aggregator LP (proxy, May 2025), Public float dominated by index funds plus value/event-driven funds accumulating the sub-$3 equity (13F coverage, 2025-2026), Sell-side: 2 Buy / 8 Hold / 2 Sell with targets clustered ~$3.25-$6 (Goldman, Morgan Stanley, Citi, Evercore ISI, June-July 2026)
Competitive set
- Chewy (NYSE: CHWY) — The structural winner in pet ecommerce: $12.60B fiscal 2025 net sales, ~21.5M active customers, 84% of sales on Autoship subscriptions, ~$8.5B market cap (July 2026) — more than 10x Petco's. Chewy strip-mines the consumables half of Petco's revenue and is now building ~in-house vet clinics, attacking the one leg (in-person care) Petco thought was safe.
- PetSmart — The mirror-image big-box rival: ~1,660 stores and roughly $9-10B estimated 2024 revenue, private under BC Partners since 2015, with Banfield hosting in-store vet clinics. Bigger than Petco in stores and revenue, carrying its own LBO debt; the two chains split a shrinking brick-and-mortar pet market while online takes the growth.
- Amazon / Walmart / Target / Costco — Mass and online generalists win on price and convenience in exactly the categories that drive Petco trips — food, litter, treats. Walmart has layered on pet pharmacy and low-cost vet clinics; grocery loss-leads national-brand kibble. This channel shift is the main reason Petco's consumables comps went negative in 2023-2025.
- Tractor Supply (Nasdaq: TSCO) — $15.5B FY2025 net sales and a ~$23.7B market cap; dominates rural/suburban pet-and-animal feed, added an online pet pharmacy (Allivet, closed Dec 2024) and out-executes Petco on loyalty (Neighbor's Club). Takes the value-oriented dog owner Petco's premium assortment priced out.
- Mars Petcare (VCA, Banfield) and vet roll-ups (Thrive, NVA) — Mars owns ~2,000+ U.S. vet hospitals/clinics across VCA and Banfield plus diagnostics (Antech); PE-backed roll-ups like Thrive Pet Healthcare and NVA consolidate the rest. They compete for the same scarce veterinarians and the same wellness-plan dollars Petco's ~300 hospitals and Vital Care memberships need to win.